Tenaya Therapeutics's top three insider shareholders as of May 14, 2026 are David V Goeddel (Director, 49.31Mn shares), David V Goeddel (Director, 9.87Mn shares), Group Iii Gp, Lp Column (TenPercentOwner, 9.87Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David V Goeddel | - | 0 | 49,313,559 | 07 Mar, 2025 |
| David V Goeddel | - | 0 | 9,870,274 | 23 Jan, 2023 |
| Group Iii Gp, Lp Column | - | 0 | 9,870,274 | 23 Jan, 2023 |
| Eli Casdin | - | 0 | 6,078,860 | 25 Nov, 2022 |
| Eli Casdin | - | 0 | 6,078,860 | 25 Nov, 2022 |
| Faraz Ali | Chief Executive Officer | 443,404 | 0 | 17 Feb, 2026 |
| Deepak Srivastava | - | 0 | 372,435 | 09 Dec, 2022 |
| Eli Casdin | - | 0 | 361,969 | 03 Aug, 2021 |
| Partners Master Fund, L.P. Casdin | - | 0 | 361,969 | 03 Aug, 2021 |
| Timothy Hoey | Chief Scientific Officer | 245,346 | 0 | 06 Mar, 2024 |
| Whittemore Tingley | Chief Medical Officer | 218,618 | 0 | 17 Feb, 2026 |
| Tomohiro Higa | Svp, Finance | 119,752 | 0 | 17 Feb, 2026 |
| Leone D Patterson | Chief Fin. And Bus. Officer | 95,755 | 0 | 27 Feb, 2024 |
| Chihiro Saito | Svp, Accounting And Fin. Ops. | 60,983 | 0 | 18 Nov, 2024 |
| Jeenjoo Kang | - | 25,000 | 0 | 03 Aug, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 24 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 309,228 | $0.62 | 1,649,281 | I | S |
| 24 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 349,212 | $0.62 | 1,862,545 | I | S |
| 25 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 1,649,281 | $0.56 | 0 | I | S |
| 25 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 1,862,545 | $0.56 | 0 | I | S |
| 20 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 245,965 | $0.61 | 2,102,218 | I | S |
| 20 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 277,769 | $0.61 | 2,374,048 | I | S |
| 23 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 143,709 | $0.60 | 1,958,509 | I | S |
| 23 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 162,291 | $0.60 | 2,211,757 | I | S |
| 17 Feb, 2026 | Whittemore Tingley | Common Stock | D | 1,642 | $0.64 | 222,136 | D | S |
| 17 Feb, 2026 | Faraz Ali | Common Stock | D | 5,851 | $0.64 | 452,415 | D | S |
| 17 Feb, 2026 | Tomohiro Higa | Common Stock | D | 611 | $0.64 | 122,610 | D | S |
| 17 Feb, 2026 | Tomohiro Higa | Common Stock | D | 836 | $0.64 | 121,774 | D | S |
| 17 Feb, 2026 | Whittemore Tingley | Common Stock | D | 1,642 | $0.64 | 220,494 | D | S |
| 17 Feb, 2026 | Faraz Ali | Common Stock | D | 3,979 | $0.64 | 448,436 | D | S |
| 17 Feb, 2026 | Faraz Ali | Common Stock | D | 5,032 | $0.64 | 443,404 | D | S |
| 17 Feb, 2026 | Whittemore Tingley | Common Stock | D | 1,876 | $0.64 | 218,618 | D | S |
| 17 Feb, 2026 | Tomohiro Higa | Common Stock | D | 2,022 | $0.64 | 119,752 | D | S |
| 10 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 161,422 | $0.82 | 4,253,298 | I | S |
| 10 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 182,295 | $0.82 | 4,803,275 | I | S |
| 11 Feb, 2026 | Group Iii Gp, Lp Column | Common Stock | D | 1,905,115 | $0.68 | 2,348,183 | I | S |